Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jan 27, 2025; 17(1): 98567
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.98567
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.98567
Factors | Infected (n = 36) | Non-infected (n = 364) | χ² | P value |
Prophylactic antibiotics use, n (%) | 13 (36.1) | 326 (89.6) | 68.34 | < 0.01 |
Intraoperative blood loss (≥ 100 mL), n (%) | 14 (38.9) | 146 (40.1) | 0 | 1 |
Age (≥ 60 years), n (%) | 20 (55.6) | 101 (27.7) | 10.72 | < 0.01 |
Hospital stay (> 5 days), n (%) | 11 (30.6) | 98 (26.9) | 0.07 | 0.79 |
Body mass index (≥ 25 kg/m²), n (%) | 15 (41.7) | 168 (46.2) | 0.12 | 0.73 |
Operation time (≥ 1 hours), n (%) | 12 (33.3) | 118 (32.4) | 0 | 1 |
Anemia, n (%) | 10 (27.8) | 58 (15.9) | 2.47 | 0.12 |
Diabetes mellitus, n (%) | 15 (41.7) | 69 (19.0) | 8.86 | < 0.01 |
Insufficient cystic duct stump, n (%) | 16 (44.4) | 36 (9.90) | 31.6 | < 0.01 |
Gallbladder perforation, n (%) | 17 (47.2) | 53 (14.6) | 22 | < 0.01 |
Gallbladder empyema, n (%) | 19 (52.8) | 61 (16.8) | 24.36 | < 0.01 |
Postoperative hematoma, n (%) | 13 (36.1) | 28 (7.7) | 25.75 | < 0.01 |
- Citation: Wang SH. Evaluating risk factors for surgical site infections and the effectiveness of prophylactic antibiotics in patients undergoing laparoscopic cholecystectomy. World J Gastrointest Surg 2025; 17(1): 98567
- URL: https://www.wjgnet.com/1948-9366/full/v17/i1/98567.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i1.98567